Φορτώνει......
Treatment options in myocarditis and inflammatory cardiomyopathy: Focus on i. v. immunoglobulins
For myocarditis and inflammatory cardiomyopathy, an etiologically driven treatment is today the best option beyond heart failure therapy. Prerequisites for this are noninvasive and invasive biomarkers including endomyocardial biopsy and polymerase chain reaction on cardiotropic agents. Imaging by Do...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Herz |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer Medizin
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096625/ https://ncbi.nlm.nih.gov/pubmed/29947834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00059-018-4719-x |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|